Skip to content
Search

Latest Stories

AstraZeneca to seek US authorization for Covid-19 vaccine this month: report

ASTRAZENECA is preparing to file for US emergency use authorization (EUA) for its Covid-19 vaccine later this month or early April after accumulating enough data to judge the inoculation's efficacy, sources with knowledge of the ongoing clinical trial told Reuters.

The British drugmaker completed enrollment in its trial of more than 32,000 volunteers in January and now has data on at least 150 cases of Covid-19, said two sources familiar with the trial.


The number of Covid-19 cases among those who got the vaccine versus infections in participants who received a placebo will show how effective the AstraZeneca shot was at preventing illness in those age 18 and over.

The AstraZeneca vaccine, developed in collaboration with Oxford University, has been authorised for use in the EU and many countries but not yet by US regulators.

"The US Phase III study results are necessary for the FDA’s evaluation of an EUA request for our vaccine," a company spokeswoman said, without confirming trial details.

"We expect data from our U.S. Phase III trial to be available soon, in the coming weeks, and we plan to file for emergency use authorisation shortly thereafter."

Highly anticipated results from the US trial could help settle safety concerns arising over reports of serious blood clots in some vaccine recipients that have led several nations to pause administering the vaccine.

A World Health Organization expert advisory committee is looking into the matter.

The data could also help determine what becomes of doses already sitting in US warehouses awaiting approval. The New York Times reported on Thursday (11) that some countries have been asking to procure doses of the vaccine not currently being offered in the US.

AstraZeneca said in February it expects its vaccine could receive US emergency use authorisation at the beginning of April and could immediately deliver 30 million doses to locations around the US.

In a Friday (12) press briefing, White House Coronavirus Response Coordinator Jeff Zients said the US has a small inventory of the AstraZeneca vaccine, which it plans to keep and deploy to Americans should an EUA be granted.

The US stance could thwart AstraZeneca’s efforts to come closer to delivering on its contractual obligation with the EU of 180 million doses in the second quarter.

AstraZeneca told the EU earlier this year it would cut its supplies in the second quarter by at least half to less than 90 million doses, EU sources said, after a bigger reduction in the first three months of the year.

More For You

Dave Myers' Iconic Bike Auctioned for £16,000 in Heartfelt Tribute

The legacy of Dave Myers is set to continue through Dave Day

Getty Images

Hairy Biker Dave Myers' last ride sells for £16,000 at auction

The motorbike that belonged to late TV personality and Hairy Bikers star Dave Myers has sold for £15,800 in a charity auction held at the National Motorcycle Museum near Solihull. The motorcycle, a BSA Goldstar, was used in the BBC's Hairy Bikers Go West, and the proceeds from its sale will benefit two charities close to Myers’ heart – NSPCC Childline and CancerCare North Lancashire & South Cumbria.

Lilian Myers, Dave Myers' wife, was keen to see the bike find a new home where it would be appreciated. "That bike still has his DNA on it," she said, expressing her hopes that the buyer would love it as much as her husband did. She added, "I am really, really happy to see this bike being loved, and I'm sure the person who got it will love it as much as Dave did."

Keep ReadingShow less
Shampoo containing deadly bacteria

Henkel is taking steps to ensure that no further contaminated products reach consumers

iStock

Shampoo containing deadly bacteria recalled due to risk of ‘serious infections’

More than 1,000 bottles of a popular shampoo sold in the United States have been recalled after being found to contain harmful bacteria that could lead to severe infections. The product in question, Tec Italy branded shampoo and conditioner for dry and damaged hair, has tested positive for the presence of Klebsiella oxytoca, a bacterium that can cause serious health complications.

Henkel, the company behind the Tec Italy brand, has recalled 1,068 units of the product as a result of the contamination. The recall comes after the U.S. Food and Drug Administration (FDA) issued a Class II designation, indicating that use of the product could result in temporary or medically reversible adverse health consequences.

Keep ReadingShow less
Coca-Cola Issues Recall for 900 Cases Due to Plastic Contamination

The recall is classified as a Class II event by the FDA

iStock

Coca-Cola recalls nearly 900 cases due to plastic contamination

Reyes Coca-Cola Bottling, LLC, based in Milwaukee, Wisconsin, has initiated a recall of nearly 900 cases of Coca-Cola Original Taste due to potential contamination with plastic. The recall affects 864 12-pack cases of Coca-Cola, which were distributed to retailers in Illinois and Wisconsin. The recall was announced on 6th March 2025, and is currently still in progress, according to the Food and Drug Administration (FDA).

The recall is classified as a Class II event by the FDA, which means that while the risk of severe health consequences is considered low, consumers may still experience temporary or reversible adverse effects. Plastic contamination in beverages poses a number of risks, including the potential for choking, oral injuries, or gastrointestinal discomfort if consumed.

Keep ReadingShow less